Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Sage Therapeutic Com (SAGE)

Sage Therapeutic Com (SAGE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,342,180
  • Shares Outstanding, K 51,148
  • Annual Sales, $ 90,270 K
  • Annual Income, $ -372,880 K
  • 60-Month Beta 2.67
  • Price/Sales 102.61
  • Price/Cash Flow N/A
  • Price/Book 7.02

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -3.32
  • Number of Estimates 12
  • High Estimate -2.89
  • Low Estimate -3.63
  • Prior Year -0.36
  • Growth Rate Est. (year over year) -822.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
164.29 +7.91%
on 05/31/19
185.60 -4.48%
on 06/20/19
+1.90 (+1.08%)
since 05/24/19
3-Month
153.93 +15.17%
on 03/25/19
185.60 -4.48%
on 06/20/19
+20.57 (+13.12%)
since 03/22/19
52-Week
79.88 +121.94%
on 12/24/18
185.60 -4.48%
on 06/20/19
+23.83 (+15.53%)
since 06/22/18

Most Recent Stories

More News
Sage Therapeutic Shares Up 21.0% Since SmarTrend's Buy Recommendation (SAGE)

SmarTrend identified an Uptrend for Sage Therapeutic (NASDAQ:SAGE) on January 7th, 2019 at $147.07. In approximately 6 months, Sage Therapeutic has returned 21.00% as of today's recent price of $177.96....

SAGE : 177.10 (-3.04%)
Look for Shares of Sage Therapeutic to Potentially Rebound after Yesterday's 2.23% Sell Off

Sage Therapeutic (NASDAQ:SAGE) traded in a range yesterday that spanned from a low of $175.92 to a high of $182.85. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of...

SAGE : 177.10 (-3.04%)
Sage Therapeutic Shares Up 18.0% Since SmarTrend's Buy Recommendation (SAGE)

SmarTrend identified an Uptrend for Sage Therapeutic (NASDAQ:SAGE) on January 7th, 2019 at $147.08. In approximately 5 months, Sage Therapeutic has returned 18.04% as of today's recent price of $173.61....

SAGE : 177.10 (-3.04%)
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on June...

SAGE : 177.10 (-3.04%)
Sage Therapeutics to Present at Goldman Sachs 40th Annual Global Healthcare Conference

Sage Therapeutics (NASDAQ:SAGE), a biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the Company will...

SAGE : 177.10 (-3.04%)
After Yesterday's Decline of 2.46%, Sage Therapeutic Offers Investors Better Value

Sage Therapeutic (NASDAQ:SAGE) traded in a range yesterday that spanned from a low of $163.84 to a high of $166.20. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of...

SAGE : 177.10 (-3.04%)
Ligand Grants Preclinical Candidate Rights to UK-based Firm

Ligand (LGND) grants exclusive worldwide rights to a pre-clinical cancer candidate discovered using Vernalis Design platform to Cumulus Oncology.

LGND : 109.89 (-1.79%)
NVS : 92.79 (+0.32%)
SAGE : 177.10 (-3.04%)
AMGN : 185.18 (-1.03%)
Sage Therapeutics to Present at 2019 RBC Capital Markets Global Healthcare Conference

Sage Therapeutics (NASDAQ:SAGE), a biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the Company will...

SAGE : 177.10 (-3.04%)
Sage Therapeutics to Present at Bank of America Merrill Lynch 2019 Health Care Conference

Sage Therapeutics (NASDAQ:SAGE), a biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the Company will...

SAGE : 177.10 (-3.04%)
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on May...

SAGE : 177.10 (-3.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade SAGE with:

Business Summary

SAGE Therapeutics Inc. is a biopharmaceutical company developing and commercializing medicines to treat life-threatening central nervous system (CNS) disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Its initial product...

See More

Key Turning Points

2nd Resistance Point 185.48
1st Resistance Point 184.07
Last Price 177.10
1st Support Level 180.15
2nd Support Level 177.65

See More

52-Week High 185.60
Last Price 177.10
Fibonacci 61.8% 145.22
Fibonacci 50% 132.74
Fibonacci 38.2% 120.27
52-Week Low 79.88

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar